Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: A Danish cohort study

Gut

Volumn 52, Issue 2, 2003, Pages 243-247

  Norgard B ^a   Fonager, K ^b   Pedersen, L ^a   Jacobsen, B A ^c   Sorensen H T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; HYDROCORTISONE; MESALAZINE; OLSALAZINE; PREDNISOLONE SODIUM SUCCINATE; PREDNISONE; STEROID;

ADULT; ADVERSE DRUG REACTION; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; HOSPITAL DISCHARGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; NEWBORN; PREGNANCY; PREMATURITY; PRENATAL DRUG EXPOSURE; PRESCRIPTION; PRIORITY JOURNAL; STILLBIRTH; ULCERATIVE COLITIS;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; DENMARK; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; MALE; MESALAMINE; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 0037302567     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.2.243     Document Type: Article

References (26)

1. Trallori G, d'Albasio G, Bardazzi G, et al. 5-Aminosalicylic acid in pregnancy: clinical report. Ital J Gastroenterol 1994;26:75-8.
2. Fedorkow DM, Persaud D, Nimrod CA. Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989;160:998-1001.
3. Willoughby CP, Truelove SC. Ulcerative colitis and pregnancy. Gut 1980;21:469-74.
4. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 5th edn. Baltimore: Williams and Wilkins, 1998.
5. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-37.
6. Christensen LA, Rasmussen SN, Hansen SH. Disposition of 5-aminosalicylic acid and N-acetyl-5-aminosalicylic acid in fetal and maternal body fluids during treatment with different 5-aminosalicylic acid preparations. Acta Obstet Gynecol Scand 1994;73:399-402.
7. Jarnerot G, Into-Malmberg MB, Esbjorner E. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol 1981;16:693-7.
8. Christensen LA, Rasmussen SN, Hansen SH, et al. Salazosulfapyridine and metabolites in fetal and maternal body fluids with special reference to 5-aminosalicylic acid. Acta Obstet Gynecol Scand 1987;66:433-5.
9. Diav-Citrin O, Park YH, Veerasuntharam G, et al. The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998;114:23-8.
10. Marteau P, Tennenbaum R, Elefant E, et al. Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules. Aliment Pharmacol Ther 1998;12:1101-8.
11. Bell CM, Habal FM. Safety of topical 5-aminosalicylic acid in pregnancy. Am J Gastroenterol 1997;92:2201-2.
12. Habal FM, Hui G, Greenberg GR. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993;105:1057-60.
13. Knudsen LB, Olsen J. The Danish Medical 8irth Registry. Dan Med Bull 1998;45:320-3.
14. Klassifikation af Sygdomme, 8. revision 2. udgave (International Classification of Disease, 8th rev, 2nd edn). Copenhagen: National Board of Health, 1986.
15. Klassifikation af Sygdomme, 10. revision 1. udgave (International Classification of Disease, 10th rev, 1st edn). Copenhagen: National Board of Health, 1993.
16. Nielsen GL, Sorensen HT, Larsen H, et al. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001;322:266-70.
17. West SL, Savitz DA, Koch G, et al. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995;142:1103-12.
18. Kristensen J, Langhoff RJ, Skovgaard LT, et al. Validation of the Danish Birth Registration. J Clin Epidemiol 1996;49:893-7.
19. Larsen H, Nielsen GL, Bendsen J, et al. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health (in press).
20. Christensen K, Knudsen LB. Registration of congenital malformations in Denmark. Dan Med Bull 1998;45:91-4.
21. Czeizel AE. First 25 years of the Hungarian congenital abnormality registry. Teratology 1997;55:299-305.
22. Mitchell AA. Special considerations in studies of drug-induced birth defects. In: Strom BL, ed. Pharmacoepidemiology, 3rd edn. Chichester: John Wiley and Sons Ltd, 2002:749-63.
23. Kornfeld D, Cnattingius S, Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - a population-based cohort study. Am J Obstet Gynecol 1997;177:942-6.
24. Fonager K, Sorensen HT, Olsen J, et al. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 1998;93:2426-30.
25. Nørgård B, Fonager K, Sørensen HT, et al. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000;95:3165-70.
26. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94.